Open AccessPalliative surgical treatment of patients, suffering proximal tumoral affection of biliary ducts and the jaundice syndrome
Author(s) -
Y. M. Susak,
R. Ya. Palytsya,
L. Yu. Маrkulan,
Olexander Dyrda
Publication year - 2020
Publication title -
klìnìčna hìrurgìâ/klìnìčna hìrurgìâ
Language(s) - English
Resource type - Journals
eISSN - 2522-1396
pISSN - 0023-2130
DOI - 10.26779/2522-1396.2020.11-12.40
Subject(s) - medicine , jaundice , endoscopic stenting , palliative treatment , surgery , pancreatitis , endoscopic treatment , stent , gastroenterology , endoscopy
Objective. To compare the efficacy of methods of miniinvasive palliative treatment of malignant hilar strictures with the jaundice syndrome.
Materials and methods. Into the investigation 71 patients, suffering proximal obturation jaundice of tumoral genesis, were included. The patients were divided into three Groups: Group I - 26 patients, to whom external-internal suprapapillary cholangiostomy was done; Group II - 28 patients, in whom transcutaneous transhepatic antegrade endobiliary stenting was performed; Group III -17 patients, to whom endoscopic retrograde biliary stenting was accomplished.
Results. Technical success in all the Groups have constituted 100%; clinical one - in 94.0%: in Group I - 96.2%, in Group II - 89.3%, and in group III - 82.4% (p>0.05). In Group I general rate of morbidity was lesser, including cholangitis and pancreatitis. The duration of cholangitis was lesser as well. Cumulative survival were the highest in Group of patients, to whom external-internal suprapapillary cholangiostomy was performed (135 days at average), while the least one - in Group of the patients, in whom endoscopic retrograde biliary stenting was done (90,6 days). In Group of patients, to whom transcutaneous transhepatic antegrade endobiliary stenting was performed, this index have constitited 101.2 days.
Conclusion. In proximal strictures of biliary ducts of tumoral genesis on background of jaundice the priority method of palliative treatment must be external-internal suprapapillary cholangiostomy, while the second-line of surgical treatment must constitute transcutaneous transhepatic antegrade endobiliary stenting. Endoscopic retrograde biliary stenting owes the lowest priority.